WO2023054795A1 - 아스코르브산을 포함하는 유분산 고형 화장료 조성물 및 이의 제조 방법 - Google Patents
아스코르브산을 포함하는 유분산 고형 화장료 조성물 및 이의 제조 방법 Download PDFInfo
- Publication number
- WO2023054795A1 WO2023054795A1 PCT/KR2021/015970 KR2021015970W WO2023054795A1 WO 2023054795 A1 WO2023054795 A1 WO 2023054795A1 KR 2021015970 W KR2021015970 W KR 2021015970W WO 2023054795 A1 WO2023054795 A1 WO 2023054795A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- oil
- cosmetic composition
- ascorbic acid
- solid cosmetic
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000002537 cosmetic Substances 0.000 title claims abstract description 53
- 235000010323 ascorbic acid Nutrition 0.000 title claims abstract description 40
- 239000011668 ascorbic acid Substances 0.000 title claims abstract description 40
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 40
- 239000007787 solid Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 21
- 229940008099 dimethicone Drugs 0.000 claims description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 18
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- 239000001993 wax Substances 0.000 claims description 17
- 239000002270 dispersing agent Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 229920006037 cross link polymer Polymers 0.000 claims description 12
- 239000000377 silicon dioxide Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 229920001296 polysiloxane Polymers 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 6
- -1 polyethylene Polymers 0.000 claims description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000011863 silicon-based powder Substances 0.000 claims description 5
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims description 4
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 4
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical group CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 4
- UNZOESWLBMZBEY-YHZPTAEISA-N bis(16-methylheptadecyl) (z)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-YHZPTAEISA-N 0.000 claims description 4
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 4
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 4
- 239000004200 microcrystalline wax Substances 0.000 claims description 4
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 4
- 239000012188 paraffin wax Substances 0.000 claims description 4
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 4
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 4
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 2
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 239000004204 candelilla wax Substances 0.000 claims description 2
- 235000013868 candelilla wax Nutrition 0.000 claims description 2
- 229940073532 candelilla wax Drugs 0.000 claims description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 2
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 2
- 239000000806 elastomer Substances 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 claims description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims description 2
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 claims description 2
- 229940073663 methyl trimethicone Drugs 0.000 claims description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 claims description 2
- 229940116351 sebacate Drugs 0.000 claims description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 claims description 2
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940086555 cyclomethicone Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 8
- 230000000052 comparative effect Effects 0.000 description 11
- 230000001351 cycling effect Effects 0.000 description 6
- 229920002545 silicone oil Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000004533 oil dispersion Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to an oil-dispersible solid cosmetic composition containing ascorbic acid and a method for preparing the same.
- Ascorbic acid also called vitamin C
- Ascorbic acid is a kind of carbohydrate synthesized from sugar precursors such as glucose or galactose. disease can be prevented.
- it has been found that it not only relieves pigmentation of the skin by inhibiting melanin formation by tyrosinase activity, but also promotes collagen protein synthesis in the body and reduces active oxygen to slow down skin aging.
- the range of use has expanded from medical use to treat deficiency diseases such as scurvy to cosmetic use to help skin whitening and anti-aging.
- Ascorbic acid reacts sensitively to external environments such as water and air, especially oxygen, heat, and light, and is easily oxidized, making it difficult to stabilize.
- an ascorbic acid component was dissolved in water or a polyol aqueous phase and stabilized by applying it to a W/O emulsification, liposome, or multi-emulsion system.
- the method of chemically binding a fat-soluble component to water-soluble ascorbic acid so that it can be dissolved in an oil phase and applying it to cosmetics has a problem in that its utilization is very low due to its very low efficiency in terms of cost. In particular, when blending at a high content, it has a great negative effect on formulation stability.
- oil-dispersed solid cosmetics have the advantage of forming an oil film when applied to the skin with a high content of oil to help moisturize the skin. I have it.
- the present inventors prepared an oil-dispersed solid cosmetic composition containing ascorbic acid, and as a result of searching for an optimal mixing ratio, the cosmetic composition was stable in formulation while containing a high content of ascorbic acid, and had excellent feeling of use and spreadability. It was confirmed that indicated
- an object of the present invention is an oil dispersion solid comprising 20.0 to 40.0% by weight of ascorbic acid, 0.1 to 3.0% by weight of a dispersant, 2.0 to 15.0% by weight of wax, 2.0 to 10.0% by weight of silicone powder, and 40.0 to 70.0% by weight of oil. It is to provide a cosmetic composition.
- Another object of the present invention is to provide a method for preparing an oil-dispersible solid cosmetic composition containing ascorbic acid, comprising the following steps:
- a second mixing step of mixing by adding silicon powder to the mixture A second mixing step of mixing by adding silicon powder to the mixture.
- the present invention relates to an oil-dispersible solid cosmetic composition containing ascorbic acid and a method for producing the same. and exhibits exfoliation.
- the inventors of the present invention have invented an oil-dispersed solid cosmetic composition that is stable and smoothly applied even when a high content of ascorbic acid is formulated, and has a differentiated feeling of use with a smooth finish that is not greasy.
- One aspect of the present invention is an oil-dispersed solid cosmetic comprising 20.0 to 40.0% by weight of ascorbic acid, 0.1 to 3.0% by weight of a dispersant, 2.0 to 15.0% by weight of wax, 2.0 to 10.0% by weight of silicone powder, and 40.0 to 70.0% by weight of oil is a composition
- the composition preferably contains 20.0 to 35.0 wt%, 20.0 to 30.0 wt%, 20.0 to 28.0 wt%, 20.0 to 26.0 wt%, 24 to 40 wt%, 24 to 35 wt%, or 24 wt% of ascorbic acid. to 30% by weight, or 24.0 to 28.0% by weight, and may include, for example, 24.0 to 26.0% by weight, but is not limited thereto.
- the composition may preferably include 0.1 to 2.0% by weight, 0.1 to 1.0% by weight, 0.5 to 3.0% by weight, or 0.5 to 2.0% by weight of the dispersant, for example, 0.5 to 1.0% by weight. %, but may include, but is not limited thereto.
- the dispersant is sorbitan isostearate, sorbitan sesquioleate, PEG-10 dimethicone, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, cetyl PEG/PPG-10/1 Dimethicone, polyglyceryl-3 polydimethylsiloxyethyl dimethicone, polyglyceryl-4 isostearate, polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate, polyglyceryl It may be at least one selected from the group consisting of -2-dipolyhydroxystearate and polyhydroxystearic acid, for example, it may be sorbitan isostearate, but is not limited thereto.
- the composition preferably contains 2.0 to 13.0% by weight, 2.0 to 12.0% by weight, 2.0 to 11.0% by weight, 7.0 to 15.0% by weight, 7.0 to 13.0% by weight, 7.0 to 12.0% by weight, 7.0 to 7.0% by weight. It may contain 11.0% by weight, 9.0 to 15.0% by weight, 9.0 to 13.0% by weight, or 9.0 to 12.0% by weight, for example, it may include 9.0 to 11.0% by weight, but is not limited thereto.
- the wax may be at least one selected from the group consisting of polyethylene, paraffin, microcrystalline wax, ceresin, candelilla wax, cowvana wax, beeswax, ozokerite, and synthetic wax.
- it may be at least one selected from the group consisting of polyethylene, paraffin, and microcrystalline wax, but is not limited thereto.
- the composition preferably contains 2.0 to 9.0% by weight, 2.0 to 8.0% by weight, 3.0 to 10.0% by weight, 3.0 to 9.0% by weight, 3.0 to 8.0% by weight, 5.0 to 10.0% by weight, 5.0% by weight to 9.0 wt%, 5.0 to 8.0 wt%, 7.0 to 10.0 wt%, or 7.0 to 9.0 wt%, for example, 7.0 to 8.0 wt%, but is not limited thereto.
- the silicone powder is polymethylsilsesquioxane, vinyl dimethicone/methicone silsesquioxane crosspolymer, silica, silica silylate, silica dimethyl silylate, elastomer, dimethicone/dimethicone crosspolymer, and diphenyldimethicone. At least one selected from the group consisting of chicon/vinyldiphenyldimethicone/silsesquioxane crosspolymer, dimethicone/vinyldimethicone crosspolymer, polysilicone-1 crosspolymer, polysilicone-11, and polysilicone-22.
- It may be, for example, at least one selected from the group consisting of polymethylsilsesquioxane, vinyldimethicone/methiconesilsesquioxane crosspolymer, silica, silica silylate, and silica dimethylsilylate. It may be, but is not limited thereto.
- the composition preferably contains 40.0 to 65.0% by weight, 40.0 to 60.0% by weight, 40.0 to 55.0% by weight, 45.0 to 70.0% by weight, 45.0 to 65.0% by weight, 45.0 to 60.0% by weight, 45.0 to 45.0% by weight. It may contain 55.0% by weight, 50.0 to 70.0% by weight, 50.0 to 65.0% by weight, or 50.0 to 60.0% by weight, for example, 50.0 to 55.0% by weight, but is not limited thereto.
- the oil is cetylethylhexanoate, hydrogenated vegetable oil, triethylhexanoin, diisostearyl maleate, and silicone oils such as dimethicone, phenyltrimethicone, diphenylsiloxyphenyltrimethicone, cyclo 1 selected from the group consisting of methicone, methyltrimethicone, cyclohexasiloxane, caprylylmethicone, diphenyldimethicone, cyclopentasiloxane, cyclopentasiloxane, trisiloxane, and dimethiconol It can be more than one species, for example, cetylethylhexanoate, hydrogenated vegetable oil, triethylhexanoin, diisostearyl maleate, VP / hexadecene copolymer, and dimethicone, which is a silicone oil, and It may be one or more
- the composition may include some of the oil as silicone oil, and therefore, the composition may contain silicone oil in an amount of 10.0 to 18.0% by weight, 10.0 to 16.0% by weight, 10.0 to 14.0% by weight, 12.0 to 20.0% by weight, It may contain 12.0 to 18.0% by weight, 12.0 to 16.0% by weight, 12.0 to 14.0% by weight, 14.0 to 20.0% by weight, or 14.0 to 18.0% by weight, for example, it may contain 14.0 to 16.0% by weight. , but is not limited thereto.
- the composition may additionally include a film former, and the film former may be a VP/hexadecene copolymer, but is not limited thereto.
- the composition may additionally include a preservative, and the preservative may be caprylyl glycol, but is not limited thereto.
- the oil-dispersed cosmetic composition may include 26.0% by weight of ascorbic acid, 1.0% by weight of dispersant, 11.0% by weight of wax, 7.1% by weight of silicone powder, and 54.35% by weight of oil. Some may be 14.0% by weight of silicone oil based on the total oil dispersion cosmetic composition.
- Another aspect of the present invention is a method for preparing an oil-dispersed solid cosmetic composition containing ascorbic acid, comprising the following steps:
- a second mixing step of mixing by adding silicon powder to the mixture A second mixing step of mixing by adding silicon powder to the mixture.
- the first mixing step and the second mixing step may be independently performed at a temperature condition of 60 to 100 ° C, preferably 60 to 95 ° C, 60 to 90 ° C, 60 to 85 ° C, 65 ° C to 100°C, 65 to 95°C, 65 to 90°C, 65 to 85°C, 70 to 100°C, 70 to 95°C, 70 to 90°C, 70 to 85°C, 75 to 100°C, 75 to 95°C, or It may be performed at a temperature condition of 75 to 90 ° C, for example, 75 to 85 ° C, but is not limited thereto.
- the second mixing step includes 20.0 to 40.0% by weight of ascorbic acid, 0.1 to 3.0% by weight of a dispersant, 2.0 to 15.0% by weight of wax, 2.0 to 10.0% by weight of silicone powder, and 40.0 to 70.0% by weight of oil. It may be to prepare a mixture.
- the present invention relates to an oil-dispersible solid cosmetic composition containing ascorbic acid and a method for producing the same, wherein the cosmetic composition contains a high content of ascorbic acid, has a stable formulation, and exhibits excellent feeling of use and spreadability. It can be effectively used in the manufacture of cosmetic compositions.
- the present invention is a solid oil dispersion comprising 20.0 to 40.0% by weight of ascorbic acid, 0.1 to 3.0% by weight of a dispersant, 2.0 to 15.0% by weight of wax, 2.0 to 10.0% by weight of silicone powder, and 40.0 to 70.0% by weight of oil. It relates to a cosmetic composition.
- % used to indicate the concentration of a particular substance is (weight/weight)% for solids/solids, (weight/volume)% for solids/liquids, and liquid/liquid is (volume/volume) %.
- Examples 1 and 2 and Comparative Examples 1 and 2 were prepared by varying the type and content of each component.
- Example 1 Comparative Example 1 Comparative Example 2 - ascorbic acid 26.00 26.00 26.00 26.00 oil Cetylethylhexanoate 16.10 16.13 16.13 16.13 Hydrogenated vegetable oil 14.90 14.87 14.87 triethylhexanoin 4.95 5.04 12.04 4.95 Diisostearyl Maleate 4.40 9.41 4.41 10.50 silicone oil dimethicone 9.00 9.00 Phenyl Trimethicone 5.00 5.00 5.00 wax polyethylene 4.50 4.50 4.50 4.50 paraffin 4.05 4.05 4.05 4.05 microcrystalline wax 2.45 3.45 2.45 3.45 silicone powder Polymethylsilsesquioxane 2.30 ⁇ ⁇ ⁇ Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer 2.00 ⁇ ⁇ ⁇ silica 1.20 ⁇ ⁇ ⁇ silica silylate 1.00 ⁇ ⁇ ⁇ Silica dimethyl silylate 0.60 1.00 ⁇ 1
- Formulation stability of the cosmetic compositions prepared in Preparation Example 1 was confirmed according to the following experimental conditions.
- Example 1 Example 2 Comparative Example 1 Comparative Example 2 1 day -4°C ⁇ ⁇ X ⁇ 25°C ⁇ ⁇ X ⁇ 37°C ⁇ ⁇ X ⁇ 45°C ⁇ ⁇ X ⁇ cycling ⁇ ⁇ X ⁇ daylight ⁇ ⁇ X ⁇ 1 week -4°C ⁇ ⁇ ⁇ ⁇ 25°C ⁇ ⁇ ⁇ ⁇ 37°C ⁇ ⁇ ⁇ ⁇ 45°C ⁇ ⁇ ⁇ ⁇ cycling ⁇ ⁇ ⁇ ⁇ daylight ⁇ ⁇ ⁇ 1 month -4°C ⁇ ⁇ ⁇ X 25°C ⁇ ⁇ ⁇ X 37°C ⁇ ⁇ ⁇ X 45°C ⁇ ⁇ ⁇ X cycling ⁇ ⁇ ⁇ X daylight ⁇ ⁇ ⁇ X 2 months -4°C ⁇ ⁇ ⁇ X 25°C ⁇ ⁇ ⁇ X 37°C ⁇ ⁇ ⁇ X 45°C ⁇ ⁇ ⁇ X cycling
- the content of ascorbic acid was analyzed while storing for 3 months at room temperature, 45° C., under sunlight exposure conditions.
- Test Example 3 Confirmation of the feeling of use of the cosmetic composition through sensory evaluation
- composition of the preparation example was evaluated according to a 5-point scale method targeting 20 women in their 20s to 40s who mainly use cosmetics.
- the feeling of use, spreadability, absorbency, stickiness, and reflected light of the cosmetic composition prepared in Preparation Example 1 were evaluated according to the following criteria. (1: very bad, 2: bad, 3: average, 4: good, 5: very good)
- Example 1 Example 2 Comparative Example 2 feeling of use 4.5 4.7 3.8 spreadability 4.4 4.6 3.9 absorbent 4.8 4.5 1.7 stickiness 4.8 4.1 1.4 reflected light 4.7 4.5 1.1
- Examples 1 and 2 were all excellent in evaluation of feeling of use, spreadability, absorbency, stickiness, and reflected light compared to Comparative Example 2. In particular, it was found that almost all evaluators felt that Example 1 was more satisfactory than Example 2 overall. In the case of Comparative Example 2, it was confirmed that absorption, stickiness, and reflected light were significantly reduced compared to Examples 1 and 2, and it was confirmed that only all the components included in Example 1 were included to exhibit excellent effects as a cosmetic composition. could
- the present invention relates to an oil-dispersible solid cosmetic composition containing ascorbic acid and a method for preparing the same.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
구분 | 성분명 | 함량 (중량%) | |||
실시예 1 | 실시예 2 | 비교예 1 | 비교예 2 | ||
- | 아스코르브산 | 26.00 | 26.00 | 26.00 | 26.00 |
오일 | 세틸에틸헥사노에이트 | 16.10 | 16.13 | 16.13 | 16.13 |
하이드로제네이티드식물성오일 | 14.90 | 14.87 | 14.87 | 14.87 | |
트라이에틸헥사노인 | 4.95 | 5.04 | 12.04 | 4.95 | |
다이아이소스테아릴말레이트 | 4.40 | 9.41 | 4.41 | 10.50 | |
실리콘오일 | 다이메티콘 | 9.00 | 9.00 | 9.00 | 9.00 |
페닐트라이메티콘 | 5.00 | 5.00 | 5.00 | 5.00 | |
왁스 | 폴리에틸렌 | 4.50 | 4.50 | 4.50 | 4.50 |
파라핀 | 4.05 | 4.05 | 4.05 | 4.05 | |
마이크로크리스탈린왁스 | 2.45 | 3.45 | 2.45 | 3.45 | |
실리콘 파우더 | 폴리메틸실세스퀴옥세인 | 2.30 | ㅡ | ㅡ | ㅡ |
비닐다이메티콘/메티콘실세스퀴옥세인크로스폴리머 | 2.00 | ㅡ | ㅡ | ㅡ | |
실리카 | 1.20 | ㅡ | ㅡ | ㅡ | |
실리카실릴레이트 | 1.00 | ㅡ | ㅡ | ㅡ | |
실리카다이메틸실릴레이트 | 0.60 | 1.00 | ㅡ | 1.00 | |
분산제 | 솔비탄아이소스테아레이트 | 1.00 | 1.00 | 1.00 | ㅡ |
필름포머 | 브이피/헥사데센코폴리머 | 0.50 | 0.50 | 0.50 | 0.50 |
보존제 | 카프릴릴글라이콜 | 0.05 | 0.05 | 0.05 | 0.05 |
실시예 1 | 실시예 2 | 비교예 1 | 비교예 2 | ||
1일 | -4℃ | ◎ | ◎ | X | ◎ |
25℃ | ◎ | ◎ | X | ◎ | |
37℃ | ◎ | ◎ | X | ◎ | |
45℃ | ◎ | ◎ | X | ◎ | |
사이클링 | ◎ | ◎ | X | ◎ | |
일광 | ◎ | ◎ | X | ◎ | |
1주 | -4℃ | ◎ | ◎ | ㅡ | △ |
25℃ | ◎ | ◎ | ㅡ | △ | |
37℃ | ◎ | ◎ | ㅡ | △ | |
45℃ | ◎ | ◎ | ㅡ | △ | |
사이클링 | ◎ | ◎ | ㅡ | △ | |
일광 | ◎ | ◎ | ㅡ | △ | |
1개월 | -4℃ | ◎ | ◎ | ㅡ | X |
25℃ | ◎ | ◎ | ㅡ | X | |
37℃ | ◎ | ◎ | ㅡ | X | |
45℃ | ◎ | ◎ | ㅡ | X | |
사이클링 | ◎ | ◎ | ㅡ | X | |
일광 | ◎ | ◎ | ㅡ | X | |
2개월 | -4℃ | ◎ | ◎ | ㅡ | X |
25℃ | ◎ | ◎ | ㅡ | X | |
37℃ | ◎ | ◎ | ㅡ | X | |
45℃ | ◎ | ◎ | ㅡ | X | |
사이클링 | ◎ | ◎ | ㅡ | X | |
일광 | ◎ | ◎ | ㅡ | X | |
3개월 | -4℃ | ◎ | ◎ | ㅡ | X |
25℃ | ◎ | ◎ | ㅡ | X | |
37℃ | ◎ | ◎ | ㅡ | X | |
45℃ | ◎ | ◎ | ㅡ | X | |
사이클링 | ◎ | ◎ | ㅡ | X | |
일광 | ◎ | ◎ | ㅡ | X |
보관조건 | 경시변화 | 분석결과 | |
함량 (중량%) | 보존률(%) | ||
상온 | 초기(initial) | 25.16 | 96.77 |
상온 | 1주 | 23.91 | 91.96 |
45℃ | 23.69 | 91.12 | |
일광 | 24.55 | 94.42 | |
상온 | 1개월 | 23.54 | 90.54 |
45℃ | 23.39 | 89.96 | |
일광 | 23.78 | 91.46 | |
상온 | 2개월 | 24.92 | 95.85 |
45℃ | 25.25 | 97.12 | |
일광 | 23.97 | 92.19 | |
상온 | 3개월 | 25.23 | 97.04 |
45℃ | 25.03 | 96.27 | |
일광 | 25.22 | 97.00 |
실시예 1 | 실시예 2 | 비교예 2 | |
사용감 | 4.5 | 4.7 | 3.8 |
발림성 | 4.4 | 4.6 | 3.9 |
흡수성 | 4.8 | 4.5 | 1.7 |
끈적임 | 4.8 | 4.1 | 1.4 |
반사광 | 4.7 | 4.5 | 1.1 |
Claims (8)
- 아스코르브산(ascorbic acid) 20.0 내지 40.0 중량%, 분산제 0.1 내지 3.0 중량%, 왁스 2.0 내지 15.0 중량%, 실리콘파우더 2.0 내지 10.0 중량%, 및 오일 40.0 내지 70.0 중량%를 포함하는 유분산 고형 화장료 조성물.
- 제1항에 있어서, 상기 분산제는 솔비탄아이소스테아레이트, 솔비탄세스퀴올리에이트, 피이지-10다이메티콘, 라우릴피이지-9폴리다이메틸실록시에틸다이메티콘, 세틸피이지/피피지-10/1다이메티콘, 폴리글리세릴-3폴리다이메틸실록시에틸다이메티콘, 폴리글리세릴-4아이소스테아레이트, 폴리글리세릴-4다이아이소스테아레이트/폴리하이드록시스테아레이트/세바케이트, 폴리글리세릴-2다이폴리하이드록시스테아레이트, 및 폴리하이드록시스테아릭애씨드로 이루어진 군으로부터 선택되는 1종 이상인 것인, 유분산 고형 화장료 조성물.
- 제1항에 있어서, 상기 왁스는 폴리에틸렌, 파라핀, 마이크로크리스탈린왁스, 세레신, 칸데릴라왁스, 카우바나 왁스, 비즈왁스, 오조케라이트, 및 합성왁스(Synthetic Wax)로 이루어진 군으로부터 선택되는 1종 이상인 것인, 유분산 고형 화장료 조성물.
- 제1항에 있어서, 상기 실리콘 파우더는 폴리메틸실세스퀴옥세인, 비닐다이메티콘/메티콘실세스퀴옥세인크로스폴리머, 실리카, 실리카 실릴레이트, 실리카다이메틸실릴레이트, 엘라스토머, 디메치콘/디메치콘크로스폴리머, 디페닐디메치콘/비닐디페닐디메치콘/실세스퀴옥산크로스폴리머, 디메치콘/비닐디메치콘 크로스폴리머, 폴리실리콘-1 크로스폴리머, 폴리실리콘-11, 및 폴리실리콘-22로 이루어진 군으로부터 선택되는 1종 이상인 것인, 유분산 고형 화장료 조성물.
- 제1항에 있어서, 상기 오일은 세틸에틸헥사노에이트, 하이드로제네이티드식물성오일, 트라이에틸헥사노인, 다이아이소스테아릴말레이트, 다이메티콘, 페닐트라이메티콘, 다이페닐실록시페닐트라이메티콘, 사이클로메치콘, 메틸트라이메티콘, 사이클로헥사실록세인, 카프릴릴메티콘, 다이페닐다이메티콘, 사이클로펜타실록세인, 사이클로펜타실록세인, 트라이실록세인, 및 다이메티콘올로 이루어진 군으로부터 선택되는 1종 이상인 것인, 유분산 고형 화장료 조성물.
- 다음 단계를 포함하는 아스코르브산(ascorbic acid)을 포함하는 유분산 고형 화장료 조성물의 제조 방법:아스코르브산, 분산제, 왁스, 및 오일을 혼합하여 혼합물을 제조하는 1차 혼합 단계; 및상기 혼합물에 실리콘 파우더를 첨가하여 혼합하는 2차 혼합 단계.
- 제6항에 있어서, 상기 1차 혼합 단계 및 2차 혼합 단계는 독립적으로 60 내지 100℃의 온도 조건에서 수행되는 것인, 유분산 고형 화장료 조성물의 제조 방법.
- 제6항에 있어서, 상기 2차 혼합 단계는 아스코르브산 20.0 내지 40.0 중량%, 분산제 0.1 내지 3.0 중량%, 왁스 2.0 내지 15.0 중량%, 실리콘파우더 2.0 내지 10.0 중량%, 및 오일 40.0 내지 70.0 중량%를 포함하는 혼합물을 제조하는 것인, 유분산 고형 화장료 조성물의 제조 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022551678A JP2023547749A (ja) | 2021-09-29 | 2021-11-05 | アスコルビン酸を含む油分散固形化粧料組成物及びその製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0128937 | 2021-09-29 | ||
KR1020210128937A KR102379257B1 (ko) | 2021-09-29 | 2021-09-29 | 아스코르브산을 포함하는 유분산 고형 화장료 조성물 및 이의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023054795A1 true WO2023054795A1 (ko) | 2023-04-06 |
Family
ID=80997069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/015970 WO2023054795A1 (ko) | 2021-09-29 | 2021-11-05 | 아스코르브산을 포함하는 유분산 고형 화장료 조성물 및 이의 제조 방법 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2023547749A (ko) |
KR (2) | KR102379257B1 (ko) |
CN (1) | CN115869208A (ko) |
WO (1) | WO2023054795A1 (ko) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070085734A (ko) * | 2005-09-09 | 2007-08-27 | 더 프록터 앤드 갬블 캄파니 | 다층을 포함하는 고형 피부 케어 조성물 |
KR101151009B1 (ko) * | 2008-10-20 | 2012-06-08 | (주)더페이스샵 | 비타민c를 안정화한 화장료 조성물 |
KR20150143698A (ko) * | 2013-04-22 | 2015-12-23 | 네오큐티스 에스아 | 항산화제 조성물 및 이의 사용 방법 |
KR20200056210A (ko) * | 2018-11-14 | 2020-05-22 | 코스맥스 주식회사 | 비수계 오일 밤 타입의 화장료 조성물 |
KR102140652B1 (ko) * | 2019-12-06 | 2020-08-03 | (주)이시스코스메틱 | 비타민 c를 포함하는 조성물 |
KR20210128937A (ko) | 2020-04-17 | 2021-10-27 | 삼성전자주식회사 | 내적 기반 신경망 가속기의 활용도를 높이기 위한 시스템 및 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101592307B1 (ko) * | 2014-04-08 | 2016-02-11 | 한국콜마주식회사 | 유용성 활성성분을 안정화한 비수계 오일 밤 타입의 화장료 조성물 및 그 제조방법 |
KR20210051331A (ko) * | 2019-10-30 | 2021-05-10 | (주)아모레퍼시픽 | 실리콘계 원료를 포함하는 입술용 화장료 조성물 |
-
2021
- 2021-09-29 KR KR1020210128937A patent/KR102379257B1/ko active IP Right Grant
- 2021-11-05 WO PCT/KR2021/015970 patent/WO2023054795A1/ko active Application Filing
- 2021-11-05 JP JP2022551678A patent/JP2023547749A/ja active Pending
-
2022
- 2022-03-03 CN CN202210206463.8A patent/CN115869208A/zh active Pending
- 2022-03-15 KR KR1020220032121A patent/KR20230046186A/ko not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070085734A (ko) * | 2005-09-09 | 2007-08-27 | 더 프록터 앤드 갬블 캄파니 | 다층을 포함하는 고형 피부 케어 조성물 |
KR101151009B1 (ko) * | 2008-10-20 | 2012-06-08 | (주)더페이스샵 | 비타민c를 안정화한 화장료 조성물 |
KR20150143698A (ko) * | 2013-04-22 | 2015-12-23 | 네오큐티스 에스아 | 항산화제 조성물 및 이의 사용 방법 |
KR20200056210A (ko) * | 2018-11-14 | 2020-05-22 | 코스맥스 주식회사 | 비수계 오일 밤 타입의 화장료 조성물 |
KR102140652B1 (ko) * | 2019-12-06 | 2020-08-03 | (주)이시스코스메틱 | 비타민 c를 포함하는 조성물 |
KR20210128937A (ko) | 2020-04-17 | 2021-10-27 | 삼성전자주식회사 | 내적 기반 신경망 가속기의 활용도를 높이기 위한 시스템 및 방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20230046186A (ko) | 2023-04-05 |
JP2023547749A (ja) | 2023-11-14 |
KR102379257B1 (ko) | 2022-03-28 |
CN115869208A (zh) | 2023-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6235292B1 (en) | Transfer-free make-up or care composition containing an organopolysiloxane and a fatty phase | |
EP0850644B1 (fr) | Composition de maquillage ou de soin ne migrant pas, contenant un organopolysiloxane solide élastomère et une phase grasse | |
US8394394B2 (en) | Mousse formulations | |
KR101044196B1 (ko) | 유중수형 에멀젼 화장용 조성물 | |
WO2011065771A2 (en) | Cosmetic composition stabilized higher oily part | |
EP0790055A1 (fr) | Utilisation d'un organopolysiloxane solide élastomère associé à une phase grasse pour la préparation d'une composition ou dans une composition de soin ou de maquillage pour matifier la peau | |
JP2002537314A (ja) | ブロック共重合体を含有する化粧品組成物 | |
US5674508A (en) | Cosmetic composition for composing sticks for the lips or the skin and processes for the preparation thereof | |
KR19980701979A (ko) | 국소용 에멀션 | |
WO2017003130A1 (ko) | 다공성 다면체 파우더를 포함하는 유중수형 화장료 조성물 | |
WO2018062725A1 (ko) | 눈썹용 메이크업 화장료 조성물 | |
WO2017003139A1 (ko) | 무수 파우더 제형 화장료 조성물 | |
US20090092567A1 (en) | Oil-containing compositions exhibiting reduced feathering | |
US20080019932A1 (en) | Color Cosmetic Compositions | |
JP3742984B2 (ja) | 油中水型乳化組成物 | |
JPH11106310A (ja) | W/o乳化組成物 | |
KR20200056210A (ko) | 비수계 오일 밤 타입의 화장료 조성물 | |
US20240065960A1 (en) | Stabilization of thiopyridinone compound in w/o composition | |
KR20000023216A (ko) | 아스코르브산을 안정화시키기 위한 실리콘 고무의 용도,및 상기 성분을 함유하는 신규 조성물 | |
JP2001505227A (ja) | 安定性無水配合品 | |
JP3515874B2 (ja) | 口紅組成物 | |
US20020015714A1 (en) | Composition comprising a hydrophilic component and a combination of a volatile compound and a phenylated silicone oil, and use thereof | |
WO2023054795A1 (ko) | 아스코르브산을 포함하는 유분산 고형 화장료 조성물 및 이의 제조 방법 | |
KR100239186B1 (ko) | 입술화장료 조성물 | |
WO2023054802A1 (ko) | 히알루론산을 포함하는 유분산 고형 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 17798726 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022551678 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21921643 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021921643 Country of ref document: EP Effective date: 20240429 |